While ILE can be a critical intervention, it is not without risks. Potential complications include fat overload syndrome, pancreatitis, and interference with laboratory assays, which may complicate the monitoring of the patient's condition. Moreover, ILE is not effective for all toxic agents, particularly those that are not highly lipophilic. Therefore, it is crucial to evaluate the risk-benefit ratio on a case-by-case basis.
